These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35169798)

  • 1. Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques.
    Chandrashekar A; Yu J; McMahan K; Jacob-Dolan C; Liu J; He X; Hope D; Anioke T; Barrett J; Chung B; Hachmann NP; Lifton M; Miller J; Powers O; Sciacca M; Sellers D; Siamatu M; Surve N; VanWyk H; Wan H; Wu C; Pessaint L; Valentin D; Van Ry A; Muench J; Boursiquot M; Cook A; Velasco J; Teow E; Boon ACM; Suthar MS; Jain N; Martinot AJ; Lewis MG; Andersen H; Barouch DH
    bioRxiv; 2022 Feb; ():. PubMed ID: 35169798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine protection against the SARS-CoV-2 Omicron variant in macaques.
    Chandrashekar A; Yu J; McMahan K; Jacob-Dolan C; Liu J; He X; Hope D; Anioke T; Barrett J; Chung B; Hachmann NP; Lifton M; Miller J; Powers O; Sciacca M; Sellers D; Siamatu M; Surve N; VanWyk H; Wan H; Wu C; Pessaint L; Valentin D; Van Ry A; Muench J; Boursiquot M; Cook A; Velasco J; Teow E; Boon ACM; Suthar MS; Jain N; Martinot AJ; Lewis MG; Andersen H; Barouch DH
    Cell; 2022 Apr; 185(9):1549-1555.e11. PubMed ID: 35427477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN.
    Yu J; Thomas PV; McMahan K; Jacob-Dolan C; Liu J; He X; Hope D; Martinez EJ; Chen WH; Sciacca M; Hachmann NP; Lifton M; Miller J; Powers OC; Hall K; Wu C; Barrett J; Swafford I; Currier JR; King J; Corbitt C; Chang WC; Golub E; Rees PA; Peterson CE; Hajduczki A; Hussin E; Lange C; Gong H; Matyas GR; Rao M; Paquin-Proulx D; Gromowski GD; Lewis MG; Andersen H; Davis-Gardner M; Suthar MS; Michael NL; Bolton DL; Joyce MG; Modjarrad K; Barouch DH
    Sci Adv; 2022 Nov; 8(47):eade4433. PubMed ID: 36417525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Dose Ad26.COV2.S Protection Against SARS-CoV-2 Challenge in Rhesus Macaques.
    He X; Chandrashekar A; Zahn R; Wegmann F; Yu J; Mercado NB; McMahan K; Martinot AJ; Piedra-Mora C; Beecy S; Ducat S; Chamanza R; Huber SR; van der Fits L; Borducchi EN; Lifton M; Liu J; Nampanya F; Patel S; Peter L; Tostanoski LH; Pessaint L; Van Ry A; Finneyfrock B; Velasco J; Teow E; Brown R; Cook A; Andersen H; Lewis MG; Schuitemaker H; Barouch DH
    bioRxiv; 2021 Jan; ():. PubMed ID: 33532782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durability of Heterologous and Homologous COVID-19 Vaccine Boosts.
    Tan CS; Collier AY; Yu J; Liu J; Chandrashekar A; McMahan K; Jacob-Dolan C; He X; Roy V; Hauser BM; Munt JE; Mallory ML; Mattocks M; Powers JM; Meganck RM; Rowe M; Hemond R; Bondzie EA; Jaegle KH; Baric RS; Schmidt AG; Alter G; Le Gars M; Sadoff J; Barouch DH
    JAMA Netw Open; 2022 Aug; 5(8):e2226335. PubMed ID: 35947380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques.
    Liu J; Yu J; McMahan K; Jacob-Dolan C; He X; Giffin V; Wu C; Sciacca M; Powers O; Nampanya F; Miller J; Lifton M; Hope D; Hall K; Hachmann NP; Chung B; Anioke T; Li W; Muench J; Gamblin A; Boursiquot M; Cook A; Lewis MG; Andersen H; Barouch DH
    Sci Immunol; 2022 Nov; 7(77):eabq7647. PubMed ID: 35943359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques.
    He X; Chandrashekar A; Zahn R; Wegmann F; Yu J; Mercado NB; McMahan K; Martinot AJ; Piedra-Mora C; Beecy S; Ducat S; Chamanza R; Huber SR; van Heerden M; van der Fits L; Borducchi EN; Lifton M; Liu J; Nampanya F; Patel S; Peter L; Tostanoski LH; Pessaint L; Van Ry A; Finneyfrock B; Velasco J; Teow E; Brown R; Cook A; Andersen H; Lewis MG; Schuitemaker H; Barouch DH
    Cell; 2021 Jun; 184(13):3467-3473.e11. PubMed ID: 34133941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.
    Yu J; Tostanoski LH; Mercado NB; McMahan K; Liu J; Jacob-Dolan C; Chandrashekar A; Atyeo C; Martinez DR; Anioke T; Bondzie EA; Chang A; Gardner S; Giffin VM; Hope DL; Nampanya F; Nkolola J; Patel S; Sanborn O; Sellers D; Wan H; Hayes T; Bauer K; Pessaint L; Valentin D; Flinchbaugh Z; Brown R; Cook A; Bueno-Wilkerson D; Teow E; Andersen H; Lewis MG; Martinot AJ; Baric RS; Alter G; Wegmann F; Zahn R; Schuitemaker H; Barouch DH
    Nature; 2021 Aug; 596(7872):423-427. PubMed ID: 34161961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques.
    Yu J; Thomas PV; Sciacca M; Wu C; Liu J; He X; Miller J; Hachmann NP; Surve N; McMahan K; Jacob-Dolan C; Powers O; Hall K; Barrett J; Hope D; Mazurek CR; Murdza T; Chang WC; Golub E; Rees PA; Peterson CE; Hajduczki A; Chen WH; Martinez EJ; Hussin E; Lange C; Gong H; Matyas GR; Rao M; Suthar M; Boursiquot M; Cook A; Pessaint L; Lewis MG; Andersen H; Bolton DL; Michael NL; Joyce MG; Modjarrad K; Barouch DH
    Cell Rep Med; 2023 Apr; 4(4):101018. PubMed ID: 37023746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques.
    Solforosi L; Costes LMM; Tolboom JTBM; McMahan K; Anioke T; Hope D; Murdza T; Sciacca M; Bouffard E; Barrett J; Wu C; Hachmann N; Miller J; Yu J; He X; Jacob-Dolan C; Huber SKR; Dekking L; Chamanza R; Choi Y; Boer KF; Barouch DH; Schuitemaker H; Zahn RC; Wegmann F
    Nat Commun; 2023 Apr; 14(1):1944. PubMed ID: 37029141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model.
    Ji Y; Sui X; Miao W; Wang C; Wang Q; Duan Z; Wei B; Wu D; Wei M; Shao J; Zheng X; Zhu T
    Vaccine; 2024 Feb; 42(6):1292-1299. PubMed ID: 38296705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaques.
    He X; Aid M; Chandrashekar A; Yu J; McMahan K; Wegmann F; Jacob-Dolan C; Maron JS; Atyeo C; Wan H; Sellers D; Liu J; Lifton M; Gardner S; Bondzie EA; Barrett J; Ahmad K; Anioke T; Yalley-Ogunro J; Muench J; Goode A; Andersen H; Lewis MG; Alter G; Schuitemaker H; Zahn R; Barouch DH
    Sci Transl Med; 2022 Mar; 14(638):eabm4996. PubMed ID: 35191769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection.
    Hyun H; Jang AY; Park H; Heo JY; Seo YB; Nham E; Yoon JG; Seong H; Noh JY; Cheong HJ; Kim WJ; Yoon SY; Seok JH; Kim J; Park MS; Song JY
    Front Immunol; 2023; 14():1131229. PubMed ID: 36960070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
    Mercado NB; Zahn R; Wegmann F; Loos C; Chandrashekar A; Yu J; Liu J; Peter L; McMahan K; Tostanoski LH; He X; Martinez DR; Rutten L; Bos R; van Manen D; Vellinga J; Custers J; Langedijk JP; Kwaks T; Bakkers MJG; Zuijdgeest D; Rosendahl Huber SK; Atyeo C; Fischinger S; Burke JS; Feldman J; Hauser BM; Caradonna TM; Bondzie EA; Dagotto G; Gebre MS; Hoffman E; Jacob-Dolan C; Kirilova M; Li Z; Lin Z; Mahrokhian SH; Maxfield LF; Nampanya F; Nityanandam R; Nkolola JP; Patel S; Ventura JD; Verrington K; Wan H; Pessaint L; Van Ry A; Blade K; Strasbaugh A; Cabus M; Brown R; Cook A; Zouantchangadou S; Teow E; Andersen H; Lewis MG; Cai Y; Chen B; Schmidt AG; Reeves RK; Baric RS; Lauffenburger DA; Alter G; Stoffels P; Mammen M; Van Hoof J; Schuitemaker H; Barouch DH
    Nature; 2020 Oct; 586(7830):583-588. PubMed ID: 32731257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients.
    GeurtsvanKessel CH; Geers D; Schmitz KS; Mykytyn AZ; Lamers MM; Bogers S; Scherbeijn S; Gommers L; Sablerolles RSG; Nieuwkoop NN; Rijsbergen LC; van Dijk LLA; de Wilde J; Alblas K; Breugem TI; Rijnders BJA; de Jager H; Weiskopf D; van der Kuy PHM; Sette A; Koopmans MPG; Grifoni A; Haagmans BL; de Vries RD
    Sci Immunol; 2022 Mar; 7(69):eabo2202. PubMed ID: 35113647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
    Costa Clemens SA; Weckx L; Clemens R; Almeida Mendes AV; Ramos Souza A; Silveira MBV; da Guarda SNF; de Nobrega MM; de Moraes Pinto MI; Gonzalez IGS; Salvador N; Franco MM; de Avila Mendonça RN; Queiroz Oliveira IS; de Freitas Souza BS; Fraga M; Aley P; Bibi S; Cantrell L; Dejnirattisai W; Liu X; Mongkolsapaya J; Supasa P; Screaton GR; Lambe T; Voysey M; Pollard AJ;
    Lancet; 2022 Feb; 399(10324):521-529. PubMed ID: 35074136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations.
    Jacobsen H; Strengert M; Maaß H; Ynga Durand MA; Katzmarzyk M; Kessel B; Harries M; Rand U; Abassi L; Kim Y; Lüddecke T; Metzdorf K; Hernandez P; Ortmann J; Heise JK; Castell S; Gornyk D; Glöckner S; Melhorn V; Kemmling Y; Lange B; Dulovic A; Marsall P; Häring J; Junker D; Schneiderhan-Marra N; Hoffmann M; Pöhlmann S; Krause G; Cicin-Sain L
    Sci Rep; 2022 Nov; 12(1):19858. PubMed ID: 36400804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial.
    Tan NH; Geers D; Sablerolles RSG; Rietdijk WJR; Goorhuis A; Postma DF; Visser LG; Bogers S; van Dijk LLA; Gommers L; van Leeuwen LPM; Boerma A; Nijhof SH; van Dort KA; Koopmans MPG; Dalm VASH; Lafeber M; Kootstra NA; Huckriede ALW; van Baarle D; Zaeck LM; GeurtsvanKessel CH; de Vries RD; van der Kuy PHM;
    Lancet Infect Dis; 2023 Aug; 23(8):901-913. PubMed ID: 37088096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant.
    Heinen N; Marheinecke CS; Bessen C; Blazquez-Navarro A; Roch T; Stervbo U; Anft M; Plaza-Sirvent C; Busse S; Klöhn M; Schrader J; Vidal Blanco E; Urlaub D; Watzl C; Hoffmann M; Pöhlmann S; Tenbusch M; Steinmann E; Todt D; Hagenbeck C; Zimmer G; Schmidt WE; Quast DR; Babel N; Schmitz I; Pfänder S
    Front Immunol; 2022; 13():1062210. PubMed ID: 36618413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant.
    Liu J; Chandrashekar A; Sellers D; Barrett J; Lifton M; McMahan K; Sciacca M; VanWyk H; Wu C; Yu J; Collier AY; Barouch DH
    medRxiv; 2022 Jan; ():. PubMed ID: 35018387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.